drugset / Trial / NCT03782532
Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma
RandomizedParallel-groupTriple-blindTreatment
Summary
Primary Objective: To evaluate the efficacy of dupilumab in patients with persistent asthma Secondary Objectives: * To evaluate the safety and tolerability of dupilumab * To evaluate the effect of dupilumab on improving patient reported outcomes including health related quality of life * To evaluate dupilumab systemic exposure and immunogenicity
Timeline
- Start
- 2019-01-25
- Primary completion
- 2022-05-21
- Completion
- 2022-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dupilumab | Monoclonal antibody | 200 mg | Subcutaneous |
| Background | Prednisolone | Other / unclassified | — | Oral |
| Background | Prednisone | Other / unclassified | — | Oral |